The intrapericardial placement of implantable cardioverter defibrillator patches has been associated with a variety of complications due to the patch-epicardial interface. Extrapericardial placement of defibrillator patches minimizes these problems. We describe a simple and reproducible technique to achieve this goal whenever a median sternotomy approach is used.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0003-4975(94)91397-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Slowly conducting anatomic isthmuses of tetralogy of Fallot: An opportunity for "prophylactic" ventricular tachycardia ablation.
Heart Rhythm
November 2024
Division of Cardiology, University of Washington Medical Center, Seattle, Washington. Electronic address:
Article Synopsis
- - Patients with repaired tetralogy of Fallot are prone to ventricular tachycardia and sudden cardiac death, with most arrhythmias linked to specific slow-conducting areas in the heart known as SCAIs.
- - The study compared a "prophylactic" approach, which involved ablating SCAIs regardless of whether VT was induced, to a "historical" approach that used VT induction to guide treatment, focusing on reducing complications and the need for implantable cardioverter-defibrillators (ICDs).
- - Results showed that patients who underwent prophylactic ablation had no major arrhythmic events over a median follow-up of 21 months, whereas 29% of the historical group
Contact allergic dermatitis to skin adhesive after CIED upgrade procedure.
J Cardiovasc Electrophysiol
December 2024
Division of Pediatric Cardiology, University of Minnesota, Minneapolis, Minnesota, USA.
Introduction: The utilization of skin adhesives for closure is typically secondary to its noninvasive application and aesthetic benefits. Allergic reactions to Dermabond™ can occur, though there are no reported cases in pediatric patients following cardiac implantable electronic device (CIED) implantation. The allergic reaction to skin glues is typically to cyanoacrylates, the primary component of Dermabond™.
View Article and Find Full Text PDFThe arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging.
Front Physiol
August 2024
National Heart and Lung Institute, Imperial College, London, United Kingdom.
Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest survivors. HCM patients surviving ventricular fibrillation or hemodynamically unstable ventricular tachycardia (n = 17) were compared to HCM patients without a personal history of potentially lethal arrhythmia (n = 20) and a pooled control group with structurally normal hearts.
View Article and Find Full Text PDFPatch Wearable Defibrillator: Excellent Therapy, But Patient Acceptance Is a Sticky Issue.
J Am Coll Cardiol
August 2024
TriHealth Heart and Vascular Institute, Cincinnati, Ohio, USA. Electronic address:
A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.
J Am Coll Cardiol
August 2024
Baylor Scott and White Research Institute, Dallas, Texas, USA; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA. Electronic address:
Background: For many patients, sudden cardiac arrest (SCA) risk is elevated temporarily. Wearable cardioverter-defibrillators (WCDs) can monitor and treat SCA during these temporary periods. Traditional WCDs can be uncomfortable, require frequent maintenance, and cannot be used when showering, resulting in poor compliance and avoidable SCA deaths.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!